Truist Securities Maintains Hold on Vericel, Raises Price Target to $39
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky maintains a 'Hold' rating on Vericel (NASDAQ:VCEL) and raises the price target from $33 to $39.
November 09, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vericel's price target has been raised from $33 to $39 by Truist Securities, while maintaining a 'Hold' rating.
The news is directly about Vericel and is likely to influence investor sentiment. The raised price target indicates a positive outlook, but the 'Hold' rating suggests that the stock is fairly valued at the moment. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100